BACK KEVIN RICHARD,CRAM MICHAEL,HARPER AIDAN JAMES,HUANG W JAMES,LILLIS JONATHAN RICHARD,LUKAS TIMOTHY MICHAEL,LUTHRA SUMIT
申请号：
IN201717015998
公开号：
IN201717015998A
申请日:
2017.05.05
申请国别(地区):
IN
年份:
2017
代理人:
摘要：
The present invention relates to a pharmaceutical aqueous formulation comprising (4 {[4 (dimethylamino)piperidin 1 yl]carbonyl}phenyl) 3 [4 (4 6 dimorpholin 4 yl 3 5 triazin 2 yl)phenyl]urea or a pharmaceutically acceptable salt thereof that is a clear solution. Such a formulation is particularly suitable for intravenous or parenteral administration to a patient.
